Aya Bassatne
Overview
Explore the profile of Aya Bassatne including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
176
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bassatne A, Murad M, Piggott T, Drake M, Rahme M, Fuleihan G
J Clin Endocrinol Metab
. 2022 Dec;
108(3):563-584.
PMID: 36545699
Background: Integrating shared decision making between patients and physicians and incorporating their values and preferences in the development of clinical practice guidelines (CPGs) is of critical importance to optimize CPG...
2.
Bassatne A, Khalil A, Chakhtoura M, Arabi A, Van Poznak C, Fuleihan G
Metabolism
. 2021 Dec;
128:154962.
PMID: 34958816
Background: Aromatase inhibitors (AIs) are routinely used to treat postmenopausal women with early-stage breast cancer. Although AIs improve breast cancer outcomes, they increase the risk of osteoporosis and fractures. This...
3.
Chakhtoura M, Bacha D, Gharios C, Ajjour S, Assaad M, Jabbour Y, et al.
J Clin Endocrinol Metab
. 2021 Oct;
107(3):882-898.
PMID: 34687206
Context: The growing number of systematic reviews/meta-analyses (SR/MAs) on vitamin D (± calcium) for fracture prevention has led to contradictory guidelines. Objective: This umbrella review aims to assess the quality...
4.
Bassatne A, Rahme M, Piggott T, Murad M, Hneiny L, Fuleihan G
BMJ Open
. 2021 Oct;
11(10):e051141.
PMID: 34635523
Introduction: Hypercalcaemia of malignancy (HCM) is the second most common cause of hypercalcaemia and is associated with significant morbidity and mortality. Several treatment options are available including pharmacological therapy with...
5.
Bassatne A, Basbous M, Chakhtoura M, El Zein O, Rahme M, Fuleihan G
Metabolism
. 2021 Mar;
119:154753.
PMID: 33774074
Background: Disease severity and mortality rates due to COVID-19 infection are greater in the elderly and chronically ill patients, populations at high risk for vitamin D deficiency. Vitamin D plays...
6.
Bassatne A, Jafari A, Kassem M, Mantzoros C, Rahme M, Fuleihan G
Bone
. 2020 Jul;
138:115510.
PMID: 32622071
Vitamin D effects on bone and mineral metabolism are well recognized, and its anti-inflammatory actions are gaining particular interest. Delta-like 1 (DLK1) is a protein, expressed by progenitor cells of...
7.
Bassatne A, Chakhtoura M, Saad R, Fuleihan G
Metabolism
. 2019 Jan;
92:193-205.
PMID: 30615949
Vitamin D deficiency is common in obese individuals and during weight loss. The recommended vitamin D doses in this specific population are higher than for healthy adults. We reviewed vitamin...
8.
Hajjar R, Bassatne A, Cheaito M, Naser El Dine R, Traboulsy S, Haddadin F, et al.
PLoS One
. 2017 Sep;
12(9):e0184662.
PMID: 28898296
Background: Studies around the world have shown that interactions between pharmaceutical companies, pharmacists and physicians have a great influence on prescribing and drug dispensing practices. In middle-income countries, the nature...